GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.50

Bid

3.50

Ask

3.70

Volume

11,867

3.10 Day's Range 3.32

2.9539 52 Week Range 16.11

Market Cap

4.308M

Previous Close

3.27

Open

3.32

Last Trade

496

3.5

(formt)

Last Trade Time

Financial Volume

$ 38,162

VWAP

3.2158

Average Volume (3m)

11,127

Shares Outstanding

1,380,633

Dividend Yield

PE Ratio

-0.57

Earnings Per Share (EPS)

-5.5

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $3.27. Over the last year, GT Biopharma shares have traded in a share price range of $ 2.9539 to $ 16.11.

GT Biopharma currently has 1,380,633 shares outstanding. The market capitalization of GT Biopharma is $4.31 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.57.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.2	6.06060606061	3.3	3.35	3.02	9034	3.22783384	CS
4	-0.3	-7.89473684211	3.8	3.88	2.9539	7013	3.28772323	CS
12	-0.54	-13.3663366337	4.04	5.21	2.9539	11127	4.23072777	CS
26	-3.4	-49.2753623188	6.9	8.7	2.9539	71271	6.66254636	CS
52	-5.329	-60.3579114282	8.829	16.11	2.9539	214267	8.57013878	CS
156	-359.8	-99.0366088632	363.3	591.993	2.9539	201984	120.51070166	CS
260	-161.5	-97.8787878788	165	591.993	2.9539	240612	153.30273756	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M